Canadian Natural Resources offers strong financials, low costs, and export growth potential with resilient cash flow and ...

Cardiff Oncology (CRDF) is a speculative buy with potential blockbuster gains ahead of its 2026 data readout. Read here for ...

But in fiscal 2024 and fiscal 2025, Applied Materials' top- and bottom-line growth accelerated again, driven by four main ...